[go: up one dir, main page]

AR063330A1 - Nanoparticulas micelares incrustadas - Google Patents

Nanoparticulas micelares incrustadas

Info

Publication number
AR063330A1
AR063330A1 ARP070104595A ARP070104595A AR063330A1 AR 063330 A1 AR063330 A1 AR 063330A1 AR P070104595 A ARP070104595 A AR P070104595A AR P070104595 A ARP070104595 A AR P070104595A AR 063330 A1 AR063330 A1 AR 063330A1
Authority
AR
Argentina
Prior art keywords
embedded
micellary
nanoparticles
micelles
solid composition
Prior art date
Application number
ARP070104595A
Other languages
English (en)
Inventor
Jan P Moschwitzer
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of AR063330A1 publication Critical patent/AR063330A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a una composicion solida termoestable que comprende micelas nano-dimensionadas de una sustancia química pobremente soluble, tal como una sustancia biologicamente activa disuelta en un material auxiliar, estando dichas micelas incrustadas en un portador soluble en agua. La invencion se relaciona adicionalmente a un proceso para preparar dicha composicion solida y a formas de dosificacion farmacéuticas preparadas a partir de esta composicion.
ARP070104595A 2006-10-20 2007-10-17 Nanoparticulas micelares incrustadas AR063330A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06122648 2006-10-20

Publications (1)

Publication Number Publication Date
AR063330A1 true AR063330A1 (es) 2009-01-21

Family

ID=37671256

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104595A AR063330A1 (es) 2006-10-20 2007-10-17 Nanoparticulas micelares incrustadas

Country Status (8)

Country Link
CN (2) CN104188926A (es)
AR (1) AR063330A1 (es)
BR (1) BRPI0719826A8 (es)
HK (1) HK1199829A1 (es)
MX (1) MX2009004124A (es)
SA (1) SA07280548B1 (es)
TW (1) TWI392507B (es)
UA (1) UA97496C2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI661841B (zh) * 2017-04-19 2019-06-11 三凡生技研發股份有限公司 用於分散疏水性植物萃取物之載劑
EP3424493A1 (en) * 2017-07-07 2019-01-09 SolMic Research GmbH Stable cannabinoid compositions
CN110302155B (zh) * 2019-07-31 2021-09-21 江南大学 一种黄原胶共聚物纳米胶束的制备方法及其应用
CN112915121A (zh) * 2019-12-06 2021-06-08 汉义生物科技（北京）有限公司 一种大麻素纳米胶束制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
EP1415648B1 (en) * 2001-07-13 2006-11-22 NanoCarrier Co., Ltd. Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
IL153277A0 (en) * 2002-12-04 2003-07-06 Pharmos Corp High enantiomeric purity dexanabinol for pharmaceutical compositions
US20060003976A1 (en) * 2004-06-04 2006-01-05 Yuehua Zhang Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds

Also Published As

Publication number Publication date
CN104188926A (zh) 2014-12-10
UA97496C2 (ru) 2012-02-27
TWI392507B (zh) 2013-04-11
CN101686946A (zh) 2010-03-31
TW200824711A (en) 2008-06-16
SA07280548B1 (ar) 2011-10-08
HK1199829A1 (en) 2015-07-24
BRPI0719826A2 (pt) 2014-05-06
BRPI0719826A8 (pt) 2017-04-04
MX2009004124A (es) 2009-07-22

Similar Documents

Publication Publication Date Title
EA200900572A1 (ru) Мицеллярные наночастицы с химическими субстанциями
GT200500045A (es) Solidos supersaturados estabilizados de drogas lipofilicas
CL2009001766A1 (es) Composicion farmaceutica solida para administracion oral que comprende: un taxano sustancialmente amorfo definido, un portador hidrofilico definido y un tensoactivo definido; metodo para preparar la composicion; y su uso para tratar una enfermedad neoplasica.
TR201902233T4 (tr) Hızlı çözünen katı dozaj formu.
GT200500155A (es) Terapia del càncer resistente al platino
WO2010128504A3 (en) Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
BR112013016772B8 (pt) compostos, uso do composto e composição farmacêutica
MX2009005727A (es) Nanoparticulas de entidad anfifilica.
EA200870219A1 (ru) Стабилизированные сукцинатом витамина е фармацевтические композиции, способы их получения и применения
CL2007002031A1 (es) Composicion farmaceutica que comprende una droga antiparasitaria insoluble en agua y un portador soluble en agua, en donde la droga se encuentra en la forma nano-dispersa; dispersion acuosa que la comprende; proceso para prepararla, util para el tratamiento o profilaxis de la malaria.
DK2054042T3 (da) Fremgangsmåder til fremstilling af biologisk aktive forbindelser i nanopartikelform
MX2013000636A (es) Nanoparticulas para encapsulacion de compuestos, su obtencion y uso.
CL2009001080A1 (es) Procedimiento para encapsular agentes biologicamente activos en un vehiculo en forma de particulas, que comprende solubilizar en un agente de apareamiento de ion hidrofobo y un disolvente, disolver, formar la emulsion y obtener el vehiculo; vehiculo en forma de particulas; y composicion farmaceutica que comprende el vehiculo.
WO2009130204A3 (en) Improved formulations for poorly permeable active pharmaceutical ingredients
BRPI0912230A2 (pt) Método para encapsular agentes biologicamente ativos em um carreador particulado, carreador particulado, e, composição farmacêutica
BRPI1010550A2 (pt) formas de dosagem, e, processo para a produção de preparações para formas de dosagem de substãncias ativas fracamente solúveis e, água.
ATE446743T1 (de) Mukosaler bioadhäsiver träger mit langsamer freisetzung zur abgabe von wirkstoffen
DE602005012289D1 (de) Abgabevehikel mit nanoteilchen
MY191875A (en) Solid dosage form
BR112012015749A2 (pt) processos para produção de um agente farmaceuticamente ativo
EA201301264A1 (ru) Способ получения неорганического материала в виде частиц
AR063330A1 (es) Nanoparticulas micelares incrustadas
BRPI0518869A2 (pt) agentes citotàxicos compreendendo taxanos
AR056369A1 (es) Compuestos derivados de quinazolina y composicion farmaceutica
CO6382108A2 (es) Nuevo procedimiento de preparacion de granulados de principios activos, y granulados tal como se los ha obtenido

Legal Events

Date Code Title Description
FA Abandonment or withdrawal